Cargando…
nab-Paclitaxel as a potential partner with checkpoint inhibitors in solid tumors
Tumors recognized by the host immune system are associated with better survival. However, the immune system is often suppressed in patients with established tumor burden. Stimulating the immune system to detect and kill tumor cells has been a challenge in cancer therapy for some time. Recently, nove...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189972/ https://www.ncbi.nlm.nih.gov/pubmed/28053544 http://dx.doi.org/10.2147/OTT.S122974 |